Valuation: IRIDEX Corporation

Market Cap 20.54M 18.05M 16.63M 15.57M 29.15M 1.94B 29.78M 200M 77.28M 957M 77.13M 75.44M 3.32B P/E 2026 *
-23x
P/E 2027 * 57.5x
Enterprise Value 20.54M 18.05M 16.63M 15.57M 29.15M 1.94B 29.78M 200M 77.28M 957M 77.13M 75.44M 3.32B EV / Sales 2026 *
0.39x
EV / Sales 2027 * 0.36x
Free-Float
68.77%
Yield 2026 *
-
Yield 2027 * -
1 day-4.24%
Current month+7.62%
1 month+11.88%
3 months-14.72%
6 months-0.88%
Current year-0.88%
1 week 1.13
Extreme 1.13
1.2
1 month 1.01
Extreme 1.01
1.2
Current year 0.95
Extreme 0.9496
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.64
Manager TitleAgeSince
Chief Executive Officer 54 2024-09-30
Director of Finance/CFO 68 2018-12-17
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 2020-06-23
Director/Board Member 54 2018-08-31
Director/Board Member 66 2022-03-16
Date Insider Type Main position Quantity % Market Cap.
Jun. 12Tax

Chief Financial Officer

-2,691 0.0155%
Jun. 12Tax

Chief Executive Officer

-3,990 0.0229%
Jun. 11Buy

Chief Financial Officer

975 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
-4.24%0.00%+19.84%-49.33% 20.54M
+1.44%+10.42%+24.93%-2.13% 188B
+1.25%-0.51%-22.42%+23.66% 142B
+1.75%+10.74%-2.39%-17.63% 137B
+0.07%-2.34%-57.59%-18.05% 65.7B
+1.18%+3.91%+17.94%+0.49% 51.66B
-0.52%-0.61%-27.14%-33.22% 43.7B
+0.37%+7.04%+14.66%+13.89% 38.27B
-0.66%+5.34%+6.97%+44.09% 37.01B
+1.26%+6.77%-9.61%-17.61% 29.54B
Average +0.19%+3.12%-3.48%-5.58% 73.21B
Weighted average by Cap. +1.03%+3.25%-3.17%-0.59%

Financials

2026 *2027 *
Net sales 53M 46.56M 42.9M 40.17M 75.21M 5B 76.85M 515M 199M 2.47B 199M 195M 8.57B 56.77M 49.87M 45.95M 43.02M 80.55M 5.36B 82.31M 552M 214M 2.65B 213M 208M 9.18B
Net income -795K -698K -644K -603K -1.13M -75.04M -1.15M -7.73M -2.99M -37.06M -2.99M -2.92M -129M 361K 317K 292K 274K 512K 34.07M 523K 3.51M 1.36M 16.83M 1.36M 1.33M 58.38M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
26-06-26 $1.150 -2.54% 29,295
26-06-25 $1.180 -0.84% 42,752
26-06-24 $1.190 +0.85% 22,719
26-06-23 $1.180 0.00% 29,304
26-06-22 $1.180 +4.42% 106,647
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.180USD
Average target price
2.750USD
Spread / Average Target
+133.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock